Presage Biosciences' Corporate Minority Round

Presage Biosciences raised a round of funding on March 06, 2013. Investors include Celgene.

Presage Biosciences is an oncology company that is pioneering an entirely novel approach to evaluating patient response to drugs in clinical trials. Using its patented CIVO technology, the company del…

Articles about Presage Biosciences' Corporate Minority Round: